{"id":523865,"date":"2021-08-05T07:04:44","date_gmt":"2021-08-05T11:04:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/"},"modified":"2021-08-05T07:04:44","modified_gmt":"2021-08-05T11:04:44","slug":"proqr-announces-second-quarter-2021-operating-and-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/","title":{"rendered":"ProQR Announces Second Quarter 2021 Operating and Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li>Top-line data from Phase 2\/3 pivotal\u00a0<em>Illuminate<\/em>\u00a0trial of sepofarsen for <em>CEP290<\/em>-mediated LCA10 on track for H1 2022<\/li>\n<li>QR-421a pivotal <em>Sirius<\/em> and <em>Celeste<\/em> Phase 2\/3 trials in Usher syndrome and retinitis pigmentosa expected to start by year end 2021<\/li>\n<li>Initial clinical data from Phase 1\/2 <em>Aurora<\/em> trial of QR-1123 for autosomal dominant retinitis pigmentosa expected in Q4 2021<\/li>\n<\/ul>\n<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug.  05, 2021  (GLOBE NEWSWIRE) &#8212; \u00a0ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update.<\/p>\n<p>\u201cAcross our pipeline, on the partnering front, and with our balance sheet, we have generated significant momentum in the first half of the year as we work to advance our therapies for patients with genetic eye disease,\u201d said Daniel A. de Boer, Founder and CEO of ProQR. \u201cWe completed enrollment in the pivotal trial of sepofarsen, reported positive clinical data for QR-421a, formed a partnership with Yarrow Biotechnology, and strengthened our financial position with a public offering.\u00a0 During the second half of the year, we expect to share the first clinical data for QR-1123 for adRP focusing on safety and tolerability, start our pivotal trials of QR-421a in Usher syndrome and nsRP, and progress enrollment of our fourth pipeline program for a genetic eye disease, QR-504a for Fuchs endothelial corneal dystrophy.\u201d<\/p>\n<p>\n        <b><br \/>\n          <b>Business Operations and Program Updates<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cioe1ATYYLgaV8T2N9oSoxCDaGoAyuw1ZyNZBVsoA2SPysZXOz7rXMijI4E4SdFjSTemYggGoxA4PDh32OduesqOyNC-GPvlVwYAH61Aa77h3U_fFEexzXtJTpXpqeNd\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <b><br \/>\n              <u>Sepofarsen<\/u><br \/>\n            <\/b><br \/>\n          <\/strong><br \/>\n        <\/a> for Leber congenital amaurosis 10 (LCA10):<\/p>\n<ul>\n<li>The Company expects to report top-line results from the pivotal Phase 2\/3 <em>Illuminate<\/em> trial in H1 2022. \u00a0The <em>Illuminate<\/em>\u00a0trial completed enrollment in January following randomization of 36 patients aged 8 years or older to receive either sepofarsen at the target registration dose, a low dose, or sham treatment. The primary endpoint for\u00a0<em>Illuminate<\/em>\u00a0is mean change from baseline in best-corrected visual acuity (BCVA) at Month 12.<\/li>\n<li>Enrollment is ongoing in the Phase 2\/3 <em>Brighten<\/em> trial of sepofarsen in LCA10. The primary objective of this study is to evaluate safety and tolerability of sepofarsen in patients under 8 years of age.<\/li>\n<\/ul>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w9ZBM58mw4JKrqtVMd5XO13ECjWLkea24PceXM0GnDyPCogkuxocItmdj_9QyzwSYLvHynJFJe1l7ySp7le0CkU55TW-pTzGbfqCqqr7u98=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <b><br \/>\n              <u>QR-421a<\/u><br \/>\n            <\/b><br \/>\n          <\/strong><br \/>\n        <\/a> for Usher syndrome and non-syndromic retinitis pigmentosa (nsRP):<\/p>\n<ul>\n<li>Based on the findings from the Phase 1\/2 <em>Stellar<\/em> trial, the Company plans to advance QR-421a into two pivotal Phase 2\/3 trials \u2013 <em>Sirius<\/em> in advanced patients, and <em>Celeste<\/em> in early-moderate patient \u2013 by year end, pending finalization of the study designs with Regulatory authorities. Each trial could potentially serve as the sole registration trial.<\/li>\n<li>In Q3, the Company expects to begin enrolling eligible patients from the Phase 1\/2 <em>Stellar<\/em> trial in the open-label extension study <em>Helia<\/em>, which will include multiple dose treatments for both eyes.<\/li>\n<\/ul>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qqoODdtUXObBaU0f2i5jMR36RykEihn3pAzgobWfx7qaIsbe6lM58B4JpyEVYTMk0HqiHHDdDwmhdt4VRWtwpsARaovHJ9Wsbyrywov51EQ=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <b><br \/>\n              <u>QR-1123<\/u><br \/>\n            <\/b><br \/>\n          <\/strong><br \/>\n        <\/a> for autosomal dominant retinitis pigmentosa (adRP):<\/p>\n<ul>\n<li>The Company has completed enrollment of the fifth single dose cohort of patients in the Phase 1\/2 <em>Aurora<\/em> trial for adRP with initial clinical data (n=11) expected in Q4. <em>Aurora<\/em> is a first-in-human clinical study, designed to evaluate safety and tolerability.\u00a0 The Company will also be looking for evidence of target engagement and\/or disease modification to inform the next steps in development.<\/li>\n<\/ul>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lNHXdbG_1icog8y30ZiCs4s_o4cYFDliYQ6tsRNtBRenlFTKdrOVtEAgKihfCfX-xkovE9Z6_vqbqkNpp_oVPFMo2IyJMvZjh-L56HeSq5b3Eh-EShc4N02rcoC25WctQbTbxuj-vPBmk_4T3XohGQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <b><br \/>\n              <u>QR-504a<\/u><br \/>\n            <\/b><br \/>\n          <\/strong><br \/>\n        <\/a> for Fuchs endothelial corneal dystrophy (FECD):<\/p>\n<ul>\n<li>The <em>Fuchs Focus<\/em> study is currently open for enrollment. This study is evaluating safety, tolerability, and molecular biomarker(s), i.e., target engagement, in the corneal endothelium following a single intravitreal injection of QR-504a in approximately 10 patients with FECD who are scheduled for corneal transplant with concurrent lens replacement.<\/li>\n<li>ProQR anticipates reporting initial data from this trial in 2022.<\/li>\n<\/ul>\n<p>Business updates:<\/p>\n<ul>\n<li>In May, Yarrow Biotechnology, Inc., an RTW Investments, LP incubated company, licensed exclusive rights to ProQR\u2019s antisense oligonucleotide technology to develop and commercialize potential therapies for an undisclosed non-ophthalmic target. Under the terms of the agreement, ProQR is eligible to receive up to $115 million of upfront and milestone payments, plus single digit percentage royalties on the net sales of any resulting products during the royalty term. ProQR will also have the right to receive an undisclosed percentage of equity in the form of shares of common stock of Yarrow.<\/li>\n<li>In April, the Company closed an underwritten public offering with gross proceeds totaling approximately $103.5 million.<\/li>\n<\/ul>\n<p>\n        <b><br \/>\n          <b>Financial Highlights<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>On June 30, 2021, ProQR held cash and cash equivalents of \u20ac139.4\u00a0 million, compared to \u20ac75.8 million on December 31, 2020. Net cash used in operating activities during the three-month period ended June 30, 2021 was \u20ac10.0 million, compared to \u20ac10.5 million for the same period last year.<\/p>\n<p>Research and development costs were \u20ac9.7 million for the quarter ended June 30, 2021 compared to \u20ac8.6 million for the same period last year.<\/p>\n<p>General and administrative costs were \u20ac4.1 million for the quarter ended June 30, 2021 compared to \u20ac3.4 million for the quarter ended June 30, 2020.<\/p>\n<p>Net loss for the three-month period ended June 30, 2021 was \u20ac15.8 million, or \u20ac0.24 per diluted share, compared to \u20ac4.1 million, or \u20ac0.08 per diluted share, for the same period last year. For further financial information for the period ending June 30, 2021, please refer to the financial statements appearing at the end of this release.<\/p>\n<p>\n        <b><br \/>\n          <b>About Leber Congenital Amaurosis 10 (LCA10)<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Leber congenital amaurosis (LCA) is the most common cause of blindness due to genetic disease in children. It consists of a group of diseases of which LCA10 is the most frequent and one of the most severe forms. LCA10 is caused by mutations in the <em>CEP290<\/em> gene, of which the p.Cys998X mutation has the highest prevalence. LCA10 leads to early loss of vision causing most people to lose their sight in the first few years of life. To date, there are no treatments approved that treat the underlying cause of the disease. Approximately 2,000 people in the Western world have LCA10 because of this mutation.<\/p>\n<p>\n        <b><br \/>\n          <b>About Sepofarsen<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Sepofarsen (QR-110) is being evaluated in the pivotal Phase 2\/3 <em>Illuminate<\/em> trial and is a first-in-class investigational RNA therapy designed to address the underlying cause of Leber congenital amaurosis 10 due to the p.Cys998X mutation (also known as the c.2991+1655A&gt;G mutation) in the <em>CEP290<\/em> gene. The p.Cys998X mutation leads to aberrant splicing of the mRNA and non-functional CEP290 protein. Sepofarsen is designed to enable normal splicing, resulting in restoration of normal (wild type) <em>CEP290<\/em> mRNA and subsequent production of functional CEP290 protein. Sepofarsen is intended to be administered through intravitreal injections in the eye and has been granted orphan drug designation in the United States and the European Union and received fast-track designation and rare pediatric disease designation from the FDA as well as access to the PRIME scheme by the EMA.<\/p>\n<p>\n        <b><br \/>\n          <b>About Usher Syndrome Type 2a and Non-Syndromic Retinitis Pigmentosa (nsRP)<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Usher syndrome is the leading cause of combined deafness and blindness. People with Usher syndrome type 2a are usually born with hearing loss and start to have progressive vision loss during adulthood. The vision loss can also occur without hearing loss in a disease called non-syndromic retinitis pigmentosa. Usher syndrome type 2a and non-syndromic retinitis pigmentosa can be caused by mutations in the <em>USH2A<\/em> gene. To date, there are no pharmaceutical treatments approved or in clinical development that treat the vision loss associated with mutations in <em>USH2A<\/em>.<\/p>\n<p>\n        <b><br \/>\n          <b>About QR-421a<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>QR-421a is a first-in-class investigational RNA therapy designed to address the underlying cause of vision loss in Usher syndrome type 2a and non-syndromic retinitis pigmentosa due to mutations in exon 13 of the\u00a0<em>USH2A<\/em>\u00a0gene. QR-421a is designed to restore functional usherin protein by using an exon skipping approach with the aim to stop or reverse vision loss in patients. QR-421a is intended to be administered through intravitreal injections in the eye and has been granted orphan drug designation in the US and the European Union and received fast-track and rare pediatric disease designations from the FDA.<\/p>\n<p>\n        <b><br \/>\n          <b>About Autosomal Dominant Retinitis Pigmentosa (adRP)<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Autosomal dominant retinitis pigmentosa, or adRP, is a severe and rare genetic disease that causes progressive problems in night vision during childhood, leading to visual field loss and frequently resulting in blindness in mid adulthood. In the United States, the most prevalent mutation associated with adRP is the P23H point mutation (also known as the c.68C&gt;A mutation) in the <em>rhodopsin (RHO)<\/em> gene and affects approximately 2,500 people. This mutation causes misfolding of the rhodopsin protein that becomes toxic to the photoreceptor cells and at the same time diminishes the function of the wild type allele. Over time this results in cell death and progressive vision loss. There are currently no therapies approved or in clinical development for P23H adRP. A natural history study in patients with P23H adRP has been conducted.<\/p>\n<p>\n        <b><br \/>\n          <b>About QR-1123<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>QR-1123 is being evaluated in the Phase 1\/2 <em>Aurora<\/em> trial and is a first-in-class investigational RNA therapy designed to treat adRP due to the P23H mutation in the <em>RHO<\/em> gene. QR-1123 was discovered and developed by Ionis Pharmaceuticals using Ionis\u2019 proprietary antisense technology. The therapy aims to inhibit the formation of the mutated toxic version of the rhodopsin protein by specifically binding the mutated <em>RHO<\/em> mRNA. Binding of QR-1123 causes allele specific knockdown of the mutant mRNA by a mechanism called RNase H mediated cleavage without affecting the normal <em>RHO<\/em> mRNA. QR-1123 is intended to be administered through intravitreal injections in the eye. QR-1123 has been granted Orphan Drug designation in the United States and received Fast Track designation from the FDA.<\/p>\n<p>\n        <b><br \/>\n          <b>About Fuchs Endothelial Corneal Dystrophy (FECD)<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Fuchs endothelial corneal dystrophy (FECD) type 3 is a common genetic disease that leads to progressive degeneration of the corneal endothelium resulting in corneal edema, scarring and vision loss. Blisters on the cornea are a major cause of pain in patients with advanced FECD. Currently there are no treatment options available to stop or slow down FECD and disease management is aimed to reduce symptoms. The only effective therapy for late-stage FECD is corneal transplantation. The availability of donors, risk of rejection, and the inherent risk of such surgeries are some of the limitations of this option. FECD is a common disorder affecting more than 4% of people over the age of 40 in the United States, with similar numbers reported for other parts of the World. Trinucleotide repeat (TNR) expansion mutations in the <em>TCF4<\/em> gene are a common cause of FECD. In people of European descent, around 75% of FECD patients have TNR expansions in <em>TCF4<\/em>.<\/p>\n<p>\n        <b><br \/>\n          <b>About QR-504a<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>QR-504a is a first-in-class investigational RNA therapy designed to address the underlying cause of Fuchs endothelial corneal dystrophy (FECD) due to trinucleotide repeat (TNR) expansion mutations in the <em>TCF4<\/em> gene. The TNR expansions cause the <em>TCF4<\/em> RNA to aggregate in the corneal endothelial cells forming the characteristic nuclear RNA foci and eventually resulting in FECD. QR-504a is designed to target the TNRs in the <em>TCF4<\/em> RNA. The aim is to reduce aggregation and the formation of RNA foci to prevent or stop corneal degeneration in patients with FECD. QR-504a is intended to be administered through intravitreal injections in the eye.<\/p>\n<p>\n        <b><br \/>\n          <b>About ProQR<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.<\/p>\n<p>Learn more about ProQR at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B7qeCb3_z_x19NSLWdoCAvMWrJTNhdsEESW2JwYsDZFg_lb_kjrok2TWGMvJduZiVx3DR2bRUxQtIrBTCCI7iw==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>www.proqr.com<\/u><\/b><\/strong><\/a>.<\/p>\n<p>\n        <b><br \/>\n          <b>FORWARD-LOOKING STATEMENTS<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;look forward to&#8221;, &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions. Such forward-looking statements include, but are not limited to, statements regarding sepofarsen (QR-110) and the clinical development and the therapeutic potential thereof, statements regarding QR-421a and the clinical development and the therapeutic potential thereof,\u00a0 statements regarding QR-1123 and the clinical development and therapeutic potential thereof, statements regarding the QR-504a and the clinical development and therapeutic potential thereof, statements regarding our pipeline of programs targeting inherited retinal dystrophies, including timing of commencing clinical trials and enrollment of patients therein, our other programs and business operations, the expected impact of the COVID-19 on our business operations, including our research and development plans and timelines and the supply chain for our clinical and development programs, statements regarding the collaboration with RTW and Yarrow and the intended benefits thereof, including milestone and royalty payments from commercial product sales, if any, from the products covered by the collaboration and the issuance of equity in Yarrow to ProQR and our financial position and cash runway. Forward-looking statements are based on management&#8217;s beliefs and assumptions and on information available to management only as of the date of this press release. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including certain sections of our annual report filed on Form 20-F. These risks and uncertainties include, among others, the cost, timing and results of preclinical studies and clinical trials and other development activities by us and our collaborative partners whose operations and activities may be slowed or halted by the COVID-19 pandemic; the likelihood of our clinical programs being executed on timelines provided and reliance on our contract research organizations and predictability of timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our reliance on contract manufacturers to supply materials for research and development and the risk of supply interruption from a contract manufacturer; the potential for future data to alter initial and preliminary results of early-stage clinical trials; the unpredictability of the duration and results of the regulatory review of applications or clearances that are necessary to initiate and continue to advance and progress our clinical programs; the ability to secure, maintain and realize the intended benefits of collaborations with partners; the possible impairment of, inability to obtain, and costs to obtain intellectual property rights; possible safety or efficacy concerns that could emerge as new data are generated in research and development; our ability to maintain and service our loan facility with Pontifax and Kreos; general business, operational, financial and accounting risks; and risks related to litigation and disputes with third parties. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.<\/p>\n<p>\n        <b><br \/>\n          <b>Cautionary Note on Future Updates<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>The statements contained in this press release reflect our current views with respect to future events, which may change significantly as the global consequences of the COVID-19 pandemic rapidly develop. Accordingly, we do not undertake and specifically disclaim any obligation to update any forward-looking statements.<\/p>\n<p>\n        <b><br \/>\n          <b>ProQR Therapeutics N.V.<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <b>Investor Contact:<\/b><br \/>\n        <br \/> Sarah Kiely<br \/> ProQR Therapeutics N.V.<br \/> T: +1 617 599 6228<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n8MH_puMnGSwYAUYFd5XgSiVObdc1QkSoovhZjOlBUmdA53g4dDSWDXvdcaOpFa2mGUzvZJwXbbzUtFiQwqVSQ==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>skiely@proqr.com<\/u><\/b><\/strong><\/a><br \/> or<br \/> Hans Vitzthum<br \/> LifeSci Advisors<br \/> T: +1 617 430 7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2trsyczD9YFeHEGc5G_Ag5j1-ZepUIPZKhcXDNfTWyujI6mXpYEmVq8-DAn_o_G7W9ZvBHGiC3BP673U1W6-CZPOkPMOcJcasrCHnPJrjsY=\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>hans@lifesciadvisors.com<\/u><\/b><\/strong><\/a><\/p>\n<p>\n        <b>Media Contact:<\/b><br \/>\n        <br \/> Cherilyn Cecchini, MD<br \/> LifeSci Communications<br \/> T: +1 646 876 5196<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TC0nuFzVNG46usdCqRxjRiP7xXCD37fZdezcoxD9Ttx2pXkZUnQSBWEUXOgHTo_HA5wFupRvbt9i8_E8LRMOwfsh_8GlesyeJIMlWt9nlZsggr0_dCUIu-ceXp-YB-34\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>ccecchini@lifescicomms.com<\/u><\/b><\/strong><\/a><\/p>\n<p>\n        \n      <\/p>\n<p>\n        <b><br \/>\n          <b>PROQR THERAPEUTICS N.V.<\/b><br \/>\n          <br \/>\n          <b> Unaudited Condensed Consolidated Statement of Financial Position<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"width:72.02%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>June\u00a030,\u00a0<\/strong>\n          <\/td>\n<td style=\"width:2.34%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>December\u00a031,\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2021<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2020<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:2.34%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Assets<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Current assets<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Cash and cash equivalents <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 139,442  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 75,838  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Prepayments and other receivables <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 3,761  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 3,762  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Social securities and other taxes <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 381  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 421  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total current assets<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>143,584 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>80,021 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Property, plant and equipment <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 17,928  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 18,601  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Investments in associates <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 224  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 107  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Investments in financial assets <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 621  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total assets<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>162,357 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>98,729 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Equity and liabilities<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Equity<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Equity attributable to owners of the Company <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 118,106  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 57,091  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Non-controlling interests <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (563) <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (545) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total equity<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>117,543 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>56,546 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Current liabilities<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Borrowings <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,562  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,135  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Lease liabilities <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,383  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,260  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Derivative financial instruments <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,617  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 839  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Trade payables <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 276  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 221  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Current income tax liability <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Social securities and other taxes <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 127  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 22  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Pension premiums <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 6  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Deferred income <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,659  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 700  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Other current liabilities <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 5,750  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 6,118  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total current liabilities<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>12,374 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>10,301 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Borrowings <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 16,972  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 16,189  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle;text-align: left;padding-left: 15.0px;border-bottom: solid black 1pt;vertical-align: top\"> Lease liabilities <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 15,468  <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 15,693  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total liabilities<\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>44,814 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>42,183 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:72.02%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total equity and liabilities<\/strong>\n          <\/td>\n<td style=\"width:2.34%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:11.04%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>162,357 <\/strong>\n          <\/td>\n<td style=\"width:2.34%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:12.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>98,729 <\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<p>\n        \n      <\/p>\n<p>\n        <b><br \/>\n          <b>PROQR THERAPEUTICS N.V.<\/b><br \/>\n          <br \/>\n          <b> Unaudited Condensed Consolidated Statement of Profit or Loss and OCI <\/b><br \/>\n        <\/b>\n      <\/p>\n<p>(\u20ac in thousands, except share and per share data)<\/p>\n<table style=\"border-collapse: collapse;width:103%;border-collapse:collapse\">\n<tr>\n<td style=\"width:60.62%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.34%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:18.12%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>Three\u00a0month\u00a0period<\/strong>\n          <\/td>\n<td style=\"width:0.2%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.72%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>Six\u00a0month\u00a0period<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:18.12%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>ended\u00a0June\u00a030,\u00a0<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.72%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>ended\u00a0June\u00a030,\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.34%;text-align: center;vertical-align: middle;vertical-align: bottom\">\n            <strong>\u00a0\u00a0\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2021<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2020<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2021<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2020<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.2%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.2%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.2%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Revenue<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>243 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u2014 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>243 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u2014 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Other income<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>411 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>8,674 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>552 <\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>8,937 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Research and development costs <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (9,735) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (8,587) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (18,640) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (21,412) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> General and administrative costs <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (4,122) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (3,446) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7,461) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7,364) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total operating costs<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(13,857)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(12,033)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(26,101)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,776)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Operating result<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(13,203)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(3,359)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(25,306)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(19,839)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Finance income and expense <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (2,464) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (697) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (2,757) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (161) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Results related to associates <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (52) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (107) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (186) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Gain on recognition of financial asset  <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 621  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Results related to financial liabilities measured at fair value through profit or loss <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (33) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (762) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Result before corporate income taxes<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(15,700)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(4,108)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,311)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(20,186)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Income taxes <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (53) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (11) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (60) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (11) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Result for the period<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(15,753)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(4,119)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,371)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(20,197)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Other comprehensive income (foreign exchange differences on foreign operation) <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (141) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (135) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 255  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 121  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total comprehensive income <\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(15,894)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(4,254)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,116)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(20,076)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Result attributable to<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Owners of the Company <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (15,746) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (4,112) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,353) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,167) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Non-controlling interests <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (18) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (30) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(15,753)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(4,119)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,371)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(20,197)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total comprehensive income attributable to<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Owners of the Company <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (15,887) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (4,247) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,098) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,046) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Non-controlling interests <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (7) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (18) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (30) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(15,894)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(4,254)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(28,116)<\/strong>\n          <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(20,076)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Share information<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Weighted average number of shares outstanding<sup>1<\/sup><\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 66,147,153  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 50,021,194  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 58,521,508  <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 49,963,614  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Earnings per share attributable to owners of the Company (Euro per share)<\/strong>\n          <\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Basic loss per share<sup>1<\/sup><\/td>\n<td style=\"width:1.34%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.24) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.08) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.48) <\/td>\n<td style=\"width:0.2%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.40) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:60.62%;border-bottom: solid black 1pt;vertical-align: top\"> Diluted loss per share<sup>1<\/sup><\/td>\n<td style=\"width:1.34%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.94%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.24) <\/td>\n<td style=\"width:0.2%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.98%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.08) <\/td>\n<td style=\"width:0.2%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.64%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.48) <\/td>\n<td style=\"width:0.2%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:9.88%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (0.40) <\/td>\n<\/tr>\n<\/table>\n<ol>\n<li>For these periods the potential exercise of share options is not included in the diluted earnings per share as the Company was loss-making. Due to the anti-dilutive nature of the outstanding options, basic and diluted earnings per share are equal.<\/li>\n<\/ol>\n<p>\n        <br \/> \u00a0<\/p>\n<p>\n        \n      <\/p>\n<p>\n        <b><br \/>\n          <b>PROQR THERAPEUTICS N.V.<\/b><br \/>\n          <br \/>\n          <b> Unaudited Condensed Consolidated Statement of Changes in Equity<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:101%;border-collapse:collapse\">\n<tr>\n<td style=\"width:23.16%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:6.3%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:6.42%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:8%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:7.18%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:0.8%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:7.22%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:0.48%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:7.68%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:5.52%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:0.6%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:6.96%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:4.14%;vertical-align: top\"> \u00a0 <\/td>\n<td> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"15\" style=\"width:62.04%;text-align: center;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>Attributable\u00a0to\u00a0owners\u00a0of\u00a0the\u00a0Company<\/strong>\n          <\/td>\n<td style=\"width:0.6%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:4.14%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top;text-align: right;vertical-align: middle\">\n            <strong>Number<\/strong><br \/>\n            <br \/>\n            <strong>of shares<\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Share<br \/> Capital<\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Share<br \/> Premium<\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Equity<\/strong><br \/>\n            <strong>\u00a0<\/strong><br \/>\n            <strong>settled<br \/> Employee<br \/> Benefit<br \/> Reserve<\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Option <br \/> premium\u00a0on<br \/> convertible<br \/> loan<\/strong>\n          <\/td>\n<td style=\"width:0.8%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Translation<br \/> Reserve<\/strong>\n          <\/td>\n<td style=\"width:0.48%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Accumulated<br \/> Deficit<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total<\/strong>\n          <\/td>\n<td style=\"width:0.6%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Non-<br \/> controlling<br \/> interests<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: top\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Total<br \/> Equity<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>\u00a0\u00a0<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:1.06%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.98%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.98%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.8%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.48%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:1%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:0.6%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:1%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Balance at January 1, 2020<\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>53,975,838 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2,159 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>287,214 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>16,551 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u2014 <\/strong>\n          <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>151 <\/strong>\n          <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(211,746)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>94,329 <\/strong>\n          <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(496)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>93,833 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Result for the period <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,167) <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,167) <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (30) <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,197) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Other comprehensive income <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 121  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 121  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 121  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Recognition of share-based payments <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 283  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 4,542  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 4,827  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 4,827  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Issuance of ordinary shares <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 100,902  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 270  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 272  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 272  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Treasury shares transferred <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (296,122) <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Share options lapsed <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (60) <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 60  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Share options exercised <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 296,122  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 712  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (458) <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 458  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 712  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 712  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Balance at June\u00a030,\u00a02020<\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>54,076,740 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2,163 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>288,479 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>20,575 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u2014 <\/strong>\n          <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>272 <\/strong>\n          <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(231,395)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>80,094 <\/strong>\n          <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(526)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>79,568 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Balance at January 1, 2021<\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>54,131,553 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2,165 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>288,757 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>23,825 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>280 <\/strong>\n          <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(189)<\/strong>\n          <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(257,747)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>57,091 <\/strong>\n          <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(545)<\/strong>\n          <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>56,546 <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Result for the period <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,353) <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,353) <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (18) <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,371) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Other comprehensive income <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 255  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 255  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 255  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Recognition of share-based payments <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 112,657  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 5  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 382  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2,719  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 3,106  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 3,106  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Issuance of ordinary shares <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 16,508,475  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 660  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 84,594  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 85,254  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 85,254  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Treasury shares transferred <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (127,303) <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Recognition of equity component of convertible loan <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Share options lapsed <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (160) <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 160  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> Share options exercised <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 243,189  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 753  <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (541) <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 541  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 753  <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 753  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.06%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.98%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.8%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.48%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:0.6%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:23.16%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Balance at June\u00a030,\u00a02021<\/strong>\n          <\/td>\n<td style=\"width:1.06%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.36%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>70,868,571 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.3%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2,830 <\/strong>\n          <\/td>\n<td style=\"width:1.06%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.42%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>374,486 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>25,843 <\/strong>\n          <\/td>\n<td style=\"width:0.98%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>280<\/strong>\n          <\/td>\n<td style=\"width:0.8%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.22%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>66 <\/strong>\n          <\/td>\n<td style=\"width:0.48%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:7.68%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(285,399)<\/strong>\n          <\/td>\n<td style=\"width:1%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:5.52%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>118,106 <\/strong>\n          <\/td>\n<td style=\"width:0.6%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:6.96%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(563)<\/strong>\n          <\/td>\n<td style=\"width:1%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"2\" style=\"width:5.18%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>117,543 <\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<p>\n        \n      <\/p>\n<p>\n        <strong><br \/>\n          <br \/>\n        <\/strong>\u00a0<\/p>\n<p>\n        <b><br \/>\n          <b>PROQR THERAPEUTICS N.V.<\/b><br \/>\n          <br \/>\n          <b> Unaudited Condensed Consolidated Statement of Cash Flows<\/b><br \/>\n        <\/b>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"width:57.64%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;border-top: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.26%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>Three\u00a0month\u00a0period\u00a0<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.26%;text-align: right;vertical-align: middle;border-top: solid black 1pt;vertical-align: bottom\">\n            <strong>Six\u00a0month\u00a0period\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>ended June\u00a030,\u00a0<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td colspan=\"3\" style=\"width:19.26%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>ended June\u00a030,\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <strong>\u00a0\u00a0\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2021<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2020<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2021<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2020<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:1.5%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u20ac\u00a0<em>1,000<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Cash flows from operating activities<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Net result <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (15,753) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (4,119) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (28,371) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (20,197) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Adjustments for: <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Depreciation <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 602  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 530  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,233  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,052  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Share-based compensation <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,471  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,802  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2,719  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 4,672  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Other income <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (8,423) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (8,423) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Financial income and expenses <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2,464  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 696  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 2,757  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 161  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Results related to associates <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 52  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 107  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 186  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Gain on recognition of financial asset <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (621) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Results related to financial liabilities measured at fair value through profit or loss <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 33  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 762  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Net foreign exchange gain \/ (loss) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (141) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (135) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 255  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 121  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u2014 Income tax expenses <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 53  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 11  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 60  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 11  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Changes in working capital <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 1,915  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (918) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 567  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (3,119) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <em>Cash used in operations<\/em>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <em>(9,356)<\/em>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <em>(10,504)<\/em>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <em>(20,532)<\/em>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\">\n            <em>\u00a0<\/em>\n          <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <em>(25,536)<\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Corporate income tax paid <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (53) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (11) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (60) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (11) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Interest received <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 5  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 62  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 5  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 91  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Interest paid <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (575) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (34) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (1,153) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (38) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong><br \/>\n              <em>Net cash used in operating activities<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(9,979)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(10,487)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(21,740)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(25,494)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Cash flow from investing activities<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Purchases of property, plant and equipment <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (52) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (344) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (84) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (542) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>\u00a0\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong><br \/>\n              <em>Net cash used in investing activities<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(52)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(344)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(84)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>(542)<\/em><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Cash flow from financing activities<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Proceeds from issuance of shares, net of transaction costs <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 82,601  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 85,254  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Proceeds from exercise of share options <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 185  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 243  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 753  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 712  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Proceeds from borrowings <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 569  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 289  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 569  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 579  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Proceeds from convertible loans <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 65  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u2014  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 65  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Repayment of lease liability <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (14) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (105) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (250) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (307) <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong><br \/>\n              <em>Net cash generated by financing activities<\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>83,341 <\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>492 <\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>86,326 <\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong><br \/>\n              <em>1,049 <\/em><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Net increase (decrease) in cash and cash equivalents<\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>73,310 <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(10,339)<\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>64,502 <\/strong>\n          <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>(24,987)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Currency effect cash and cash equivalents <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (1,746) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (583) <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> (898) <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 178  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> Cash and cash equivalents, at beginning of the period <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 67,878  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 98,063  <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 75,838  <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> 111,950  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<td style=\"width:2.36%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0\u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:57.64%;border-bottom: solid black 1pt;vertical-align: top\">\n            <strong>Cash and cash equivalents at the end of the period<\/strong>\n          <\/td>\n<td style=\"width:2.36%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>139,442 <\/strong>\n          <\/td>\n<td style=\"width:2.36%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>87,141 <\/strong>\n          <\/td>\n<td style=\"width:1.5%;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>139,442 <\/strong>\n          <\/td>\n<td style=\"width:2.36%;border-bottom: solid black 1pt;vertical-align: bottom\"> \u00a0 <\/td>\n<td style=\"width:8.44%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>87,141 <\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/8aa90157-1856-48aa-953a-cfed0ce3520a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Top-line data from Phase 2\/3 pivotal\u00a0Illuminate\u00a0trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 QR-421a pivotal Sirius and Celeste Phase 2\/3 trials in Usher syndrome and retinitis pigmentosa expected to start by year end 2021 Initial clinical data from Phase 1\/2 Aurora trial of QR-1123 for autosomal dominant retinitis pigmentosa expected in Q4 2021 LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) &#8212; \u00a0ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update. \u201cAcross our pipeline, on the partnering front, and with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProQR Announces Second Quarter 2021 Operating and Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-523865","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Top-line data from Phase 2\/3 pivotal\u00a0Illuminate\u00a0trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 QR-421a pivotal Sirius and Celeste Phase 2\/3 trials in Usher syndrome and retinitis pigmentosa expected to start by year end 2021 Initial clinical data from Phase 1\/2 Aurora trial of QR-1123 for autosomal dominant retinitis pigmentosa expected in Q4 2021 LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) &#8212; \u00a0ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update. \u201cAcross our pipeline, on the partnering front, and with &hellip; Continue reading &quot;ProQR Announces Second Quarter 2021 Operating and Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-05T11:04:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProQR Announces Second Quarter 2021 Operating and Financial Results\",\"datePublished\":\"2021-08-05T11:04:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/\"},\"wordCount\":3062,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/\",\"name\":\"ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\",\"datePublished\":\"2021-08-05T11:04:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-second-quarter-2021-operating-and-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProQR Announces Second Quarter 2021 Operating and Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk","og_description":"Top-line data from Phase 2\/3 pivotal\u00a0Illuminate\u00a0trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 QR-421a pivotal Sirius and Celeste Phase 2\/3 trials in Usher syndrome and retinitis pigmentosa expected to start by year end 2021 Initial clinical data from Phase 1\/2 Aurora trial of QR-1123 for autosomal dominant retinitis pigmentosa expected in Q4 2021 LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) &#8212; \u00a0ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update. \u201cAcross our pipeline, on the partnering front, and with &hellip; Continue reading \"ProQR Announces Second Quarter 2021 Operating and Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-05T11:04:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"15 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProQR Announces Second Quarter 2021 Operating and Financial Results","datePublished":"2021-08-05T11:04:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/"},"wordCount":3062,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/","name":"ProQR Announces Second Quarter 2021 Operating and Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==","datePublished":"2021-08-05T11:04:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMDA2MSM0MDEwMTMzNDEjMjAxMTE2Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-second-quarter-2021-operating-and-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProQR Announces Second Quarter 2021 Operating and Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=523865"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523865\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=523865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=523865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=523865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}